Alpha Teknova raises 2026 revenue guidance after record quarter
The reagent maker reported second quarter 2026 revenue of $12.2 million, up 18%, and lifted its full-year revenue outlook to $45-47 million.
Alpha Teknova, Inc. announced financial results for the second quarter ended June 30, 2026 on August 5, 2026, alongside an updated fiscal 2026 outlook. Second quarter 2026 total revenue reached $12.2 million, up 18% compared to $10.3 million for the second quarter of 2025.1
The company said this marked a milestone. CEO Stephen Gunstream said this was the first time Teknova delivered more than $12 million in quarterly revenue, with growth across nearly all of the end markets it serves.1
On the product side, Teknova highlighted a new tool for developers. Following a second quarter beta release, the company launched Build-Tek, an AI-powered evolution of its custom configurator first introduced in 2024, which it said now lets therapeutic and diagnostic developers build complex custom products in minutes.1
Looking at the outlook, the company raised its guidance for the full year. Teknova raised its fiscal 2026 outlook for revenue to $45 million to $47 million for the year ending December 31, 2026, and also improved its expectation for Free Cash Outflow to less than $8 million.1 CFO Matt Lowell tied the revision to the quarter's performance. Lowell said the company delivered 18% revenue growth and a significant improvement in Free Cash Outflow in the second quarter compared to 2025, prompting the raised revenue guidance and the reduced Free Cash Outflow expectation for the full year.1
On cash position, the balance sheet showed the following as of the reporting date. Total cash and short-term investments stood at $17.4 million, with total borrowings of $13.2 million at the end of the second quarter of 2026.1 Cash used in operating activities for the quarter was $0.5 million, down from $2.1 million a year earlier, while Free Cash Outflow was $0.6 million compared to $2.3 million in the prior-year quarter.1
Teknova is scheduled to present at two upcoming investor conferences: the Sidoti Microcap Conference (Virtual) on August 19-20, 2026, and the ROTH Healthcare Opportunities Conference in New York, NY on September 29, 2026.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.